Organization: Health Canada
Year: 2024
Month: February
Request Number: A-2022-000996
Request Summary: The disclosable inspection document(s) listing the Inspector’s detailed observations, conditions found, and any follow-up expected by Health Canada for the human drugs drug establishment licence Good Pharmacovigilance Practices (GVP) inspection of the Gilead Sciences Canada facility (Site A) on Mississauga Road, Mississauga, Ontario starting around 19 July 2021. Reference Number 502703.
Disposition: Disclosed in part
Number of pages: 56